微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains
RSS 官方收录 · 可信分层展示
关键摘要
On Feb.…
- 24, 2025, the Food and Drug Administration did something it arguably s…
- For anyone who treats serious mental illness, this is welcome news.
- But I want to say something more complicated about it, because I have …
摘要引擎：抽取
正文提要
On Feb. 24, 2025, the Food and Drug Administration did something it arguably should have done long ago: It removed the elaborate monitoring program that has governed one of psychiatry’s most important drugs, clozapine, for more than 30 years. For anyone who treats serious mental illness, this is welcome news.
But I want to say something more complicated about it, because I have spent a large part of my career prescribing this drug (or trying to) to the most vulnerable population there is: children with psychosis. The paperwork was never really the problem.